{
    "code": "60001021",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001021",
    "time": "2021-11-26 06:08:24",
    "許可證字號": "衛部菌疫輸字第001021號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/07\/11",
    "發證\/登錄日期": "105\/07\/11",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000102105",
    "中文品名": "恩必喜凍晶注射劑",
    "英文品名": "Empliciti TM (elotuzumab) For Injection",
    "適應症": "1. 與lenalidomide及dexamethasone併用，治療之前曾接受過一至三種療法的多發性骨髓瘤成年病人。\r\n2. 與pomalidomide及 dexamethasone 併用，治療之前曾接受過至少兩種療法 (包括 lenalidomide 和蛋白酶體抑制劑) 的多發性骨髓瘤成年病人。",
    "劑型": "243凍晶注射劑",
    "包裝": "20毫升小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/07\/11",
    "主成分略述": "Elotuzumab",
    "限制項目": "02輸　入 1E須執行Phase IV Study 5F免除銜接性試驗",
    "申請商名稱": "1404501100  台灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FIT0404000  CATALENT ANAGNI S.R.L.",
            "製造廠廠址": "LOCALITA&#39; FONTANA DEL CERASO SNC, STRADA PROVINCIALE CASILINA, 41, ANAGNI (FR), 03012, ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0037000  BRISTOL-MYERS SQUIBB COMPANY",
            "製造廠廠址": "6000 THOMPSON ROAD, SYRACUSE, NEW YORK 13321-4755, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0885000  BRISTOL-MYERS SQUIBB COMPANY",
            "製造廠廠址": "38 JACKSON ROAD, DEVENS,MASSACHUSETTS 01434 ,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013005800",
            "成分名稱": "Elotuzumab",
            "含量描述": "Elotuzumab (BMS-901608)",
            "含量": "440.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1013005800",
            "成分名稱": "Elotuzumab",
            "含量描述": "Elotuzumab (BMS-901608)",
            "含量": "340.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "恩必喜凍晶注射劑_仿單-110-09-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001021&Seq=003&Type=9"
        },
        {
            "title": "恩必喜凍晶注射劑(400mg)_外盒-110-09-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001021&Seq=008&Type=8"
        },
        {
            "title": "恩必喜凍晶注射劑(300mg)_外盒-110-09-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001021&Seq=007&Type=8"
        }
    ]
}